DuPage Medical Group Enrolling Patients for National Brain-Scanning Research StudyApril 18, 2016
IDEAS Study Uses PET Imaging to Help Clarify Diagnosis of Dementia
DOWNERS GROVE, Ill. – Specialists from DuPage Medical Group, the largest independent, multi-specialty physician group in the Chicago area, are enrolling qualified patients for a new study on dementia. Through this research, high-tech PET imaging is being utilized to help detect the core feature of Alzheimer’s and other dementias.
DMG is one of only four groups in Illinois participating in the IDEAS (Imaging Dementia – Evidence for Amyloid Scanning) study. DMG is one of the first healthcare providers in the country to enroll patients and complete an amyloid PET scan.
An amyloid is an accumulation of proteins in the brain that are toxic to brain cells and potentially lead to Alzheimer’s and other neurological disease. IDEAS is a four-year research project that seeks to demonstrate the usefulness of amyloid PET imaging and represents a potential major advancement in the clinical assessment of people with cognitive impairment. Researchers hope to identify, enroll and examine more than 18,000 Medicare patients for IDEAS. The study hopes to improve outcomes for patients suffering with dementia, including diagnosis and treatment management. The study is sponsored by the Alzheimer's Association and managed by the American College of Radiology and the American College of Radiology Imaging Network.
IDEAS is not recruiting patients directly. Candidates are being identified and enrolled by DMG board-certified neurologist and dementia specialist Dr. Chris Simon. PET scans will then be performed by DMG’s radiology department and interpreted by board-certified radiologists, sub-specialized in PET/CT. Scan results and diagnosis will also be captured and shared with the ordering physician and researchers. Under this study, Medicare will provide coverage for one amyloid PET scan per patient enrolled.
“We’re proud to have DMG specialists participating in such an innovative study,” says Dennis Fine, DMG chief operating officer. “A swift and accurate diagnosis has a huge impact on access to Alzheimer's treatments, eligibility for research trials, plus much-needed support and information services.”
If you or someone you care for is a Medicare patient suffering from dementia, talk to your neurologist to see if you may qualify for the IDEAS study. Learn more about the study protocol at IDEAS-Study.org.
About DuPage Medical Group
With more than 490 physicians and in more than 70 locations, DuPage Medical Group is the largest independent, multi-specialty physician group in the Chicago area, providing physician-directed health care focused on quality, efficiency and access. For more information, visit www.dupagemedicalgroup.com.